The ADA now recommends KERENDIA in their
2022 Standards of Medical Care in Diabetes1
The ADA now recommends KERENDIA in their
2022 Standards of Medical Care in Diabetes1
In adult patients with CKD associated with T2D
With KERENDIA,
a different pathway
leads to different
possibilities2,3
KERENDIA offers a different path forward
© 2022 Bayer. All rights reserved. BAYER, the Bayer Cross,
and KERENDIA are registered trademarks of Bayer.
All other trademarks are the property of their respective owners.
Last updated 04/22
You are encouraged to report side effects or quality complaints of products to
the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088.
Contact us for medical information or questions.
© 2022 Bayer. All rights reserved. BAYER, the Bayer Cross,
and KERENDIA are registered trademarks of Bayer.
All other trademarks are the property of their respective owners.
Last updated 04/22
You are encouraged to report side effects or quality complaints of products to
the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088.
Contact us for medical information or questions.